Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Change in Receivables (2016 - 2025)

Healthstream (HSTM) has disclosed Change in Receivables for 16 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 19.23% to $5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 million, a 841.71% increase, with the full-year FY2025 number at $4.0 million, up 841.71% from a year prior.
  • Change in Receivables was $5.0 million for Q4 2025 at Healthstream, up from $2.4 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $10.0 million in Q4 2022 to a low of -$7.4 million in Q1 2021.
  • A 5-year average of -$118550.0 and a median of -$329500.0 in 2021 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: plummeted 498.03% in 2021, then surged 181.87% in 2022.
  • Healthstream's Change in Receivables stood at $3.6 million in 2021, then skyrocketed by 181.87% to $10.0 million in 2022, then crashed by 60.3% to $4.0 million in 2023, then grew by 5.52% to $4.2 million in 2024, then rose by 19.23% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Change in Receivables are $5.0 million (Q4 2025), $2.4 million (Q3 2025), and -$4.5 million (Q2 2025).